Nanoparticle formulation of ormeloxifene for pancreatic cancer

Pancreatic cancer is the fourth most prevalent cancer with about an 85% mortality rate; thus, an utmost need exists to discover new therapeutic modalities that would enhance therapy outcomes of this disease with minimal or no side effects. Ormeloxifene (ORM), a synthetic molecule, has exhibited pote...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biomaterials
Glavni autori: Khan, Sheema, Chauhan, Neeraj, Yallapu, Murali M., Ebeling, Mara C., Balakrishna, Swathi, Ellis, Robert T., Thompson, Paul A., Balabathula, Pavan, Behrman, Stephen W., Zafar, Nadeem, Singh, Man Mohan, Halaweish, Fathi T., Jaggi, Meena, Chauhan, Subhash C.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405677/
https://ncbi.nlm.nih.gov/pubmed/25890768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2015.02.082
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items